Collaboration - December 11, 2018
AstraZeneca and Chalmers Ventures enter partnership
Through the new partnership AstraZeneca will become a Knowledge Partner to Chalmers Ventures and selected startups from Chalmers Venture’s portfolio will get the opportunity to receive counselling from AstraZeneca’s mentor program AZ Exchange Mentoring. “This setup is both an important and a fun step forward for us as an incubator and accelerator,” says Linnéa Lindau, CEO […]
Collaboration - December 10, 2018
AstraZeneca and Cancer Research UK launch functional genomics centre
AstraZeneca announces a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines. The Functional Genomics Centre will further develop CRISPR technology to better understand the biology of cancer, creating biological models that may be more reflective […]
Collaboration - December 5, 2018
Evotec and LEO Pharma form drug discovery alliance
The new integrated drug discovery alliance’s goal is to generate new leads against innovative targets for a range of dermatological conditions and initially runs for two years. The collaboration leverages Evotec’s hit identification platform including the screening, structural biology and fragment-based drug design capabilities and expertise together with LEO Pharma’s drug development and advancing science in […]
Collaboration - November 27, 2018
BC Platforms and University of Nottingham create health data discovery platform
BC Platforms has entered into a research collaboration with the UK’s national biobanking platform in order to enable clinical and genetic data to be integrated, supported by the recently established Health Data Research UK; a research institute set up to help improve lives through better use of data. The biobanking platform – directory.biobankinguk.org – is […]
Collaboration - November 19, 2018
Immunicum enters collaboration with big pharma
The company will collaborate with Merck and Pfizer to evaluate ilixadencel, an off-the-shelf cell-based cancer immune primer, in combination with avelumab, a human anti-PD-L1 monoclonal antibody, in a planned multi-indication Phase Ib/II clinical trial. Immunicum will initiate a study of ilixadencel in the fourth quarter of 2018. Following completion of the Ib portion of the study, […]
Collaboration - November 16, 2018
Medicon Valley: Cross-border strengths
Despite a current slowdown in growth rate, Medicon Valley still ranks high among Europe’s life science clusters. Right now, the region is going through an interesting transition period to remain the key gateway to Nordic life science. “The life science industry in the region has links back to the agricultural industry and breweries, such as […]
